ONDANSETRON IS NOT ASSOCIATED WITH VASCULAR ADVERSE EVENTS, THROMBOCYTOPENIA OR RENAL-FAILURE

被引:8
作者
CASTLE, WM
CUNNINGHAM, K
KANAREK, BB
机构
[1] GLAXO GRP RES LTD,INT MED AFFAIRS,INFECT & ONCOL,GREENFORD UB6 0HE,MIDDX,ENGLAND
[2] GLAXO INC RES INST,CLIN RES,RALEIGH,NC
关键词
D O I
10.1093/oxfordjournals.annonc.a058340
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:773 / 774
页数:2
相关论文
共 1 条
[1]   SEVERE VASCULAR ADVERSE-EFFECTS WITH THROMBOCYTOPENIA AND RENAL-FAILURE FOLLOWING EMETOGENIC CHEMOTHERAPY AND ONDANSETRON [J].
COATES, AS ;
CHILDS, A ;
COX, K ;
FORSYTH, C ;
JOSHUA, DE ;
MCNEIL, E ;
GRYGIEL, JJ .
ANNALS OF ONCOLOGY, 1992, 3 (09) :719-722